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OBJECTIVE — Diabetes during pregnancy is a strong risk factor for obesity in the offspring,
but the age at which this association becomes apparent is unknown. The purpose of this study
was to examine the relation of glycemia during pregnancy with anthropometry in offspring of
nondiabetic pregnant women from the Belfast U.K. center of the multinational Hyperglycemia
and Adverse Pregnancy Outcome (HAPO) Study.
RESEARCH DESIGN AND METHODS — Women from the HAPO Study were invited
toparticipateinfollow-upoftheiroffspringaged2years.Measurementsincludedheight,weight,
and thickness of triceps, subscapular, and suprailiac skinfolds.
RESULTS — Atotalof1,165offspring(73%ofeligiblechildren;598boysand567girls)were
seen from ages 22–30 completed months. The only association that reached statistical signiﬁ-
cance was between categories of maternal 1-h glucose and BMI Z score 85th percentile at 2
years(P0.017).OverallthecorrelationsbetweenmaternalglucoseduringpregnancyandBMI
Z score at age 2 years were weak (fasting glucose r  0.05, P  0.08; 1-h glucose r  0.04, P 
0.22; 2-h glucose r  0.03, P  0.36; and area under the curve for glucose r  0.04, P  0.18).
CONCLUSIONS — This study found little association between maternal glucose during
pregnancyandobesityintheoffspringatthisyoungage.Theseﬁndingsarenotunexpectedgiven
that study results for young offspring whose mothers had diabetes during pregnancy were
indistinguishablefromthosefornormaloffspringatthisage.Itwillbeinterestingtoseewhether,
as these children age, maternal glucose during pregnancy in the ranges included in the HAPO
Study will be associated with obesity in their children.
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D
iabetes during pregnancy, whether
gestational diabetes, preexisting
type 1 diabetes, or preexisting type
2 diabetes, has long-lasting effects on the
offspring, resulting in higher rates of obe-
sity (1–3) and type 2 diabetes (4,5) and
lesser degrees of abnormal glucose toler-
ance (5,6) and an earlier age of onset of
maturity-onset diabetes of the young (7)
andoftype2diabetes(8).Type2diabetes
or impaired glucose tolerance developing
at young ages results in a higher rate of
pregnancies being complicated by diabe-
tes in the next generation (9). Potential
long-term effects of degrees of abnormal
glucose tolerance during pregnancy less
than what is generally considered to be
diabetes have not been well studied.
Among nondiabetic Pima Indians of Ari-
zona, a linear relationship was observed
between the mother’s glucose concentra-
tion measured during the third trimester
of pregnancy and both the relative weight
and the 2-h postload glucose concentra-
tionintheiroffspringafterage5years(9).
Whether this will be a universal ﬁnding
and, if so, at what age the impact of hy-
perglycemia during pregnancy will ﬁrst
be identiﬁable are unknown. A unique
opportunity to follow children whose
mothers had hyperglycemia during preg-
nancy, but short of diabetes, as demon-
strated on an oral glucose tolerance test
(OGTT) is presented by the offspring of
women participating in the Hyperglyce-
mia and Adverse Pregnancy Outcome
(HAPO) Study (10). This article presents
the association between glycemia during
pregnancy and anthropometry in chil-
dren aged 2 years participating in the
HAPO Family Study at the Belfast Center.
RESEARCH DESIGN AND
METHODS— Details of the HAPO
Study have been reported elsewhere (10),
andtheprimaryresultswerepublishedin
2008(11).Inbrief,theHAPOstudywasa
15-centermulticulturalstudydesignedto
examine the association between mater-
nalhyperglycemiaandadversepregnancy
outcomes among women with singleton
pregnancies whose OGTT results were
below the thresholds that have tradition-
ally deﬁned gestational diabetes. Each
woman underwent a 75-g OGTT at
24–32 weeks of gestation. Women and
their caregivers remained blinded to the
results of the OGTT as long as the fasting
glucosedidnotexceed105mg/dl,the2-h
glucoseconcentrationdidnotexceed200
mg/dl, the woman was not hypoglycemic
(glucose 45 mg/dl) at any time, and no
random glucose concentration measured
between34and37weeksofgestationwas
160 mg/dl. The study showed that the
four primary outcomes (birth weight
90th percentile, primary cesarean de-
livery, neonatal hypoglycemia, and cord
blood C-peptide 90th percentile) were
all signiﬁcantly positively associated with
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ing the OGTT (11).
AllwomenfromtheBelfastU.K.Cen-
ter who participated in the HAPO Study
were invited, along with their 2-year-old
offspring, to participate in the HAPO
Family Study. Examination of the 2-year-
old (range 22–30 completed months) off-
spring included measurements of weight
to the nearest 0.1 kg (SECA model 708;
Seca, Birmingham, U.K.), height to the
nearest 0.1 cm (Leicester height measure
stadiometer; Seca), head circumference
andmid-armcircumferencetothenearest
0.1 cm and triceps, subscapular, and su-
prailiac skinfold thicknesses to the near-
est 0.1 mm (Holtain skinfold calipers;
Holtain, Crymych, U.K.). These skinfold
measurements were added to give a sum-
mary measure of subcutaneous fat. BMI
was calculated as weight in kilograms di-
vided by the square of height in meters
and converted to SD or Z score using
1990 standards for British children (12).
Z scores were also calculated for height
and weight and for head circumference
(12). Birth weight Z scores, speciﬁc for
gestationalage,werealsocalculatedbased
on standards for the U.K. (12) and were
used to determine small for gestational
age (10th percentile) and large for ges-
tational age (90th percentile).
TheHAPOStudystratiﬁedtheresults
of each of the three OGTT glucose con-
centrations (fasting, 1-h, and 2-h) into
seven categories and determined the rates
of primary outcomes in each stratum
(11). For this article, because of the
smaller numbers enrolled in a single cen-
ter, the upper two OGTT glucose strata
were combined, leaving six categories of
glucoseateachofthethreetimepoints.In
addition, the area under the curve of the
maternal OGTT was calculated (13).
All statistical analyses were done us-
ing SPSS (SPSS, Chicago, IL). The charac-
teristics of male and female participants
were compared using the independent
samplesZtestandforthecategoricalvari-
ables (BMI Z score 85 percentile and
95 percentile) a 
2 test. The relation-
shipbetweentheresultsoftheOGTTper-
formed between 24 and 32 weeks of
gestation (in six categories) and various
pregnancy outcome measures (birth
weight 90th percentile for gestational
age,BMI85thor95thpercentilesatage
2years)wereassessedusingthe
2testfor
trend.Thistestwasalsousedtoassessthe
relationship between ordered categories
of birth weight, neonatal skinfold thick-
ness, and cord C-peptide results and
Table 1—Characteristics of subjects examined at age 2 years (range 22–30 months)
Male Female P value
n 598 567
Age (years) 2.15  0.11 2.14  0.11 0.07
Height (cm) 88.8  3.6 87.5  3.6 0.001
Height Z score 0.19  1.15 0.12  1.11 0.28
Weight (kg) 13.9  1.6 13.2  1.6 0.001
Weight Z score 0.64  1.01 0.57  1.02 0.19
BMI (kg/m
2) 17.6  1.5 17.2  1.6 0.001
BMI Z score 0.67  1.05 0.59  1.09 0.18
BMI Z score 85% 219/587 (37.3) 183/554 (33.0) 0.13
BMI Z score 95% 104/587 (17.7) 86/554 (15.5) 0.32
Head circumference (cm) 50.3  1.4 49.1  1.4 0.001
Head circumference Z score 0.12  1.05 0.09  1.18 0.64
Arm circumference (cm) 16.0  1.5 15.8  1.3 0.02
Triceps skinfold (mm) 11.4  2.4 11.6  2.5 0.13
Subscapular skinfold (mm) 6.3  1.9 6.7  2.0 0.001
Suprailiac skinfold (mm) 7.8  3.0 8.4  3.0 0.002
Sum of skinfolds (mm) 25.5  6.1 26.7  6.1 0.001
Data are means  SD or n (%).
Table 2—LGA (birth weight >90th percentile for gestational age), overweight, and obesity
(BMI Z scores >85th and 95th percentiles, respectively) at age 2 years according to strata of
maternal OGTT glucose at 24–32 weeks of gestation
LGA (birth)
Overweight
(age 2 years)
Obesity (age
2 years)
Fasting glucose
75 mg/dl 2/68 (2.9) 17/66 (25.8) 11/66 (16.7)
75–79 mg/dl 14/308 (4.5) 105/296 (35.5) 50/296 (16.9)
80–84 mg/dl 26/394 (6.6) 134/386 (34.7) 55/386 (14.2)
85–89 mg/dl 27/230 (11.7) 81/229 (35.4) 36/229 (15.7)
90–94 mg/dl 13/125 (10.4) 51/125 (40.8) 29/125 (23.2)
95 mg/dl 11/40 (27.5) 14/39 (35.9) 9/39 (23.1)
Ptrend 0.001 0.16 0.16
1-h glucose
106 mg/dl 8/176 (4.5) 50/171 (29.2) 24/171 (14.0)
106–132 mg/dl 17/388 (4.4) 123/382 (32.2) 58/382 (15.2)
133–155 mg/dl 34/332 (10.2) 127/324 (39.2) 61/324 (18.8)
156–171 mg/dl 16/156 (10.3) 58/153 (37.9) 30/153 (19.6)
172–193 mg/dl 12/83 (14.5) 32/81 (39.5) 11/81 (13.6)
194 mg/dl 6/30 (20.0) 12/30 (40.0) 6/30 (20.0)
Ptrend 0.001 0.017 0.27
2-h glucose
91 mg/dl 10/187 (5.3) 54/183 (29.5) 26/183 (14.2)
91–108 mg/dl 28/455 (6.2) 156/445 (35.1) 75/445 (16.9)
109–125 mg/dl 23/299 (7.7) 105/293 (35.8) 49/293 (16.7)
126–139 mg/dl 17/129 (13.2) 52/127 (40.9) 26/127 (20.5)
140–157 mg/dl 6/67 (9.0) 23/65 (35.4) 9/65 (13.8)
158 mg/dl 9/28 (32.1) 12/28 (42.9) 5/28 (17.9)
Ptrend 0.001 0.06 0.49
Area under the curve for glucose
196 mg/dl   h 11/200 (5.5) 59/195 (30.3) 31/195 (15.9)
196–228 mg/dl   h 17/389 (4.4) 132/381 (34.6) 57/381 (15.0)
229–256 mg/dl   h 29/308 (9.4) 109/302 (36.1) 52/302 (17.2)
257–276 mg/dl   h 15/137 (10.9) 54/135 (40.0) 28/135 (20.7)
277–303 mg/dl   h 12/96 (12.5) 35/93 (37.6) 17/93 (18.3)
304 mg/dl   h 9/35 (25.7) 13/35 (37.1) 5/35 (14.3)
Ptrend 0.001 0.10 0.34
Data are n/total n (%). LGA, large for gestational age.
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at age 2 years. Correlation coefﬁcients
were calculated, and multiple regression
analyses were performed to assess the as-
sociation between pregnancy/neonatal
characteristicsandthechild’sBMIZscore
andskinfoldthicknessmeasurementsat2
years of age. Skinfold thickness measure-
ments were added to give a summary
measure. Because the distributions of
skinfold thickness were positively
skewed, their sum was logarithmically
transformed before these analyses.
RESULTS— The HAPO Study en-
rolled1,649CaucasianwomenintheBel-
fast Center, 1,612 of whom remained
blinded throughout pregnancy. Twenty-
eight non-Caucasian subjects, predomi-
nantly Asian, are not included in this
article.NineoftheCaucasianpregnancies
ended in stillbirth or perinatal death. By
thetimeofthe2-yearexamination,259of
the children had moved or were lost to
follow-up, 51 refused, and 128 were un-
able to keep their scheduled appoint-
ments. Follow-up examinations were
therefore performed on 1,165 (72%) of
the surviving children of Caucasian
HAPO participants who had remained
blinded throughout the pregnancy study
(Table 1). Boys were taller and heavier
than girls with a higher BMI and larger
head circumference (P  0.001 for each)
but had slightly smaller skinfold thick-
nesses (sum of skinfold difference  1.2
mm, P  0.001). Z scores for height,
weight, BMI, and head circumference
were not signiﬁcantly different between
the sexes. The mothers of the nonre-
sponders were younger (27.8 vs. 30.4
years),lesslikelytobemarried(49.4%vs.
70.1%), more likely to smoke (37.4% vs.
19.0%), and more likely to drink regu-
larly (30.4% vs. 25.6%, all P  0.05). Al-
though the 1-h glucose and the A1C were
also signiﬁcantly lower among the nonre-
sponders (132 vs. 135 mg/dl and 4.7 vs.
4.8%, P  0.05 for each), these differ-
ences were clinically small.
Table 2 shows rates of birth weight
90thpercentileand,in2yearolds,rates
of overweight (BMI Z score 85th per-
centile) and obesity (BMI Z score 95th
percentile) according to the six categories
ofmaternalOGTTglucoseconcentrations
and area under the curve for glucose dur-
ing pregnancy. Maternal glucose concen-
trations in the Belfast cohort, as in the
HAPO Study as a whole (11), were di-
Figure 1—Correlation coefﬁcients show the relation between 1-h glucose during the pregnancy OGTT and BMI SD score and sum of the skinfolds
in the offspring at age 2 years. Left, boys; right, girls.
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90th percentile among those subjects
whowereseensubsequentlyatage2years
(left column of Table 2). The only other
association that reached statistical signif-
icancewasbetweencategoriesofmaternal
1-h glucose and a BMI Z score at 2 years
85th percentile (
2 for trend  5.32,
df  1, P  0.017), but the overall corre-
lation between maternal glucose during
pregnancy and BMI Z score at age 2 years
was weak (fasting glucose r  0.05, P 
0.08; 1-h glucose r  0.04, P  0.22; 2-h
glucose r  0.03, P  0.36; and area un-
der the curve r  0.04, P  0.18). Weak
correlations were found between moth-
er’s 1-h glucose and both the (log-
transformed) suprailiac skinfold (r 
0.07,P0.02)andsumofskinfolds(r
0.07, P  0.03) at 2 years, this latter cor-
relation being most notable in boys (r 
0.10, P  0.02) (Fig. 1).
Table 3 shows the association be-
tween overweight, obesity, and sum of
skinfolds 90th percentile at age 2 years
according to categories of weight at birth,
sum of skinfolds at birth, and cord blood
C-peptide. Both measures of neonatal fat-
ness (birth weight and sum of skinfolds)
wereassociatedwithoverweightandobe-
sity at age 2 (P  0.01 for each), but C-
peptide was not.
Table 4 shows the results of regres-
sion models with BMI Z score and sum of
skinfoldsatage2yearsasdependentvari-
ables. Neither outcome was associated
with maternal glucose during pregnancy
either before or after adjustment for other
variables. Age at examination was signiﬁ-
cantly associated with the BMI Z score,
and sex was signiﬁcantly associated with
the sum of skinfolds in both simple and
multiple regression analysis. Birth weight
Z score, sum of skinfolds at birth, and
maternal BMI were associated with both
the BMI Z score and sum of skinfolds at
age 2 years in simple regression analyses.
However, after backward elimination of
nonsigniﬁcant variables, only birth
weight Z score and maternal BMI re-
mained independent predictors of BMI Z
score at age 2 years, whereas only sum of
skinfolds at birth was an independent
predictor of sum of skinfolds at age 2
years.
CONCLUSIONS — This article re-
ports the ﬁrst of periodic examinations
planned for the offspring of the women
participatingintheHAPOStudyfromthe
Table3—Overweight,obesity,andsumofskinfolds>90thpercentileatage2yearsaccording
to birth parameters
Overweight (BMI Z
scores 85th
percentile)
Obesity (BMI Z
scores 95th
percentile)
Sum of skinfolds
90th percentile
Birth weight category
SGA (10th percentile) 31/117 (26.5) 14/117 (12.0) 9/108 (8.3)
Normal 325/935 (34.8) 149/935 (15.9) 82/859 (9.5)
LGA (90th percentile) 46/89 (51.7) 27/89 (30.3) 13/79 (16.5)
Ptrend 0.001 0.001 0.09
Sum of skin folds at birth
25th percentile 88/275 (32.0) 39/275 (14.2) 20/256 (7.8)
25–74th percentile 173/547 (31.6) 77/547 (14.1) 41/502 (8.2)
75th percentile 116/261 (44.4) 59/261 (22.6) 33/234 (14.1)
Ptrend 0.003 0.009 0.02
Cord C-peptide
25th percentile 97/285 (34.0) 47/285 (16.5) 27/254 (10.6)
25–74th percentile 151/435 (34.7) 73/435 (16.8) 30/392 (7.7)
75th percentile 89/247 (36.0) 38/247 (15.4) 23/235 (9.8)
Ptrend 0.63 0.74 0.72
Data are n/total n (%). LGA, large for gestational age; SGA, small for gestational age.
Table 4—Summary of regression analyses with BMI Z score and sum of skinfolds as dependent variables showing regression coefﬁcients (95%
CI) from simple regression analysis and multiple regression after backward elimination of nonsigniﬁcant variables
Independent
variables
BMI Z score at age 2 years Sum of skin folds at age 2 years§
Simple regression
(95% CI)
Multiple regression
(95% CI)# Simple regression (95% CI) Multiple regression (95% CI)††
n 1,082 990
AUC for maternal
glucose
(mg/dl   hr)† 0.001 (0.001 to 0.003) 0.001 (0.002 to 0.001) 0.0001 (0.0000 to 0.0003) 0.0001 (0.0001 to 0.0003)
Age at examination
(years) 0.85 (0.25 to 1.44)** 0.79 (0.22 to 1.37)** 0.012 (0.069 to 0.046) 0.001 (0.056 to 0.058)
Male sex 0.06 (0.07 to 0.18) 0.07 (0.05 to 0.19) 0.022 (0.034 to 0.010)*** 0.019 (0.031 to 0.007)**
Birth weight Z score 0.29 (0.22 to 0.35)*** 0.26 (0.19 to 0.32)*** 0.013 (0.006 to 0.019)*** —
Sum of skin folds at
birth‡ 1.64 (0.95 to 2.33)*** — 0.140 (0.073 to 0.207)*** 0.120 (0.051 to 0.188)***
Maternal BMI (kg/
m
2) at 24–30
weeks of
gestation 0.038 (0.024 to 0.052)*** 0.027 (0.012 to 0.040)** 0.002 (0.000 to 0.003)** —
†AUC, area under the curve for maternal pregnancy OGTT. ‡Sum of triceps, subscapular and suprailiac (ﬂank) skin folds (log10-transformed). §Sum of triceps,
subscapular, and suprailiac skin folds (log10-transformed). #Maternal glucose, age, and sex all forced into model (R
2  0.078). ††Maternal glucose, age, and sex all
forced into model (R
2  0.027). **P  0.01; ***P  0.001.
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the major strengths of this study is the
high rate of follow-up of the two-year-old
offspring. This is largely the result of low
rates of emigration from the community
in Northern Ireland and will facilitate fur-
ther contact with these subjects at older
ages. The fact that this is part of a larger
family follow-up further adds to recruit-
ment because the HAPO Study mothers
are also participating in the survey rather
than just bringing their children for the
examinations.Becausethisstudywaslim-
ited to Caucasian subjects in the Belfast
Center, these data will complement pre-
vious ﬁndings among nondiabetic
women in a non-Caucasian group (9).
Both birth weight and sum of skin-
folds, as a measure of fetal response to
maternal glucose, but not maternal glu-
cose itself, were predictive of BMI Z score
atage2years.Ageatexaminationwasalso
signiﬁcantly associated with BMI Z score
at 2 years, suggesting that even over a
6-month period at this young age chil-
dren in Northern Ireland are becoming
heavier relative to the U.K. standards. At
age 2 years, correlations between the ma-
ternal glucose concentrations during the
OGTT and anthropometric measure-
ments in the offspring are weak. The aim
of this article was to examine the associa-
tion of maternal glucose and other prena-
tal and perinatal risk factors with
childhood obesity, as has been done in
previous studies. Consideration of later
environmentalriskfactors,suchastypeof
infantfeedingandactivity,areoutsidethe
scope of this article. In other studies in-
volvingoffspringofwomenwithfrankdi-
abetes during pregnancy, the obesity
associated with elevated maternal glucose
concentrations resolved during the 1st
year or 2 of life so that the offspring of
diabetic women were of normal weight
(14,15), even though long-term the asso-
ciations between maternal diabetes and
both obesity and abnormal glucose toler-
ancerecurredatolderages(1–6).Itisnot
surprising, therefore, that in this study of
offspring of women with normal glucose
tolerance during pregnancy there was lit-
tle association between maternal glucose
concentrations and anthropometric mea-
surements at age 2 years. Whether or not
we will see a recurrence of the associa-
tions that were so strong at birth as these
children age remains to be seen.
Acknowledgments— We would like to ac-
knowledge the HAPO Study Cooperative
Group and the staff of the HAPO Family
Study. The HAPO study was funded by grants
from the National Institute of Child Health
andHumanDevelopmentandtheNationalIn-
stitute of Diabetes and Digestive and Kidney
Diseases (RO1-HD34242 and RO1-
HD34243) and Diabetes UK (RD04/
0002756), which supported the enrollment
and collection of data on participants. This
study was supported by a research grant from
the Northern Ireland Research and Develop-
ment Ofﬁce.
No potential conﬂicts of interest relevant to
this article were reported.
Parts of this study were presented in ab-
stract form at the 68th annual meeting of the
American Diabetes Association, San Fran-
cisco, California, 6–10 June 2008.
References
1. Pettitt DJ, Baird HR, Aleck KA, Bennett
PH, Knowler WC. Excessive obesity in
offspring of Pima Indian women with di-
abetes during pregnancy. N Engl J Med
1983;308:242–245
2. Silverman BL, Landsberg L, Metzger BE.
Fetal hyperinsulinism in offspring of
diabetic mothers. Association with the
subsequent development of childhood
obesity. Ann NY Acad Sci 1993 Oct 29;
699:36–45
3. Pettitt DJ, Knowler WC, Bennett PH,
Aleck KA, Baird HR. Obesity in offspring
of diabetic Pima Indian women despite
normal birthweight. Diabetes Care 1987;
10:76–80
4. Pettitt DJ, Aleck KA, Baird HR, Carraher
MJ,BennettPH,KnowlerWC.Congenital
susceptibility to NIDDM: role of intra-
uterine environment. Diabetes 1988;37:
622–628
5. Clausen TD, Mathiesen ER, Hansen T,
Pedersen O, Jensen DM, Lauenborg J,
Damm P. High prevalence of type 2 dia-
betes and pre-diabetes in adult offspring
of women with gestational diabetes melli-
tus or type 1 diabetes: the role of intra-
uterine hyperglycemia. Diabetes Care
2008;31:340–346
6. Silverman BL, Metzger BE, Cho NH, Loeb
CA. Impaired glucose tolerance in adoles-
cent offspring of diabetic mothers. Rela-
tionship to fetal hyperinsulinism. Diabetes
Care 1995 May;18:611–617
7. Stride A, Shepherd M, Frayling TM, Bul-
man MP, Ellard S, Hattersley AT. Intra-
uterine hyperglycemia is associated with
anearlierdiagnosisofdiabetesinHNF-1
gene mutation carriers. Diabetes Care
2002;25:2287–2291
8. Pettitt DJ, Lawrence JM, Beyer J, Hillier
TA,LieseAD,Mayer-DavisB,LootsB,Im-
peratore G, Liu L, Dolan LM, Linder B,
Dabelea D. Association between maternal
diabetes in utero and age of offspring’s
diagnosis of type 2 diabetes. Diabetes
Care 2008;31:2126–2130
9. Pettitt DJ, Bennett PH, Saad MF, Charles
MA, Nelson RG, Knowler WC. Abnormal
glucose tolerance during pregnancy in
Pima Indian women: long-term effects on
the offspring. Diabetes 1991;40(Suppl.
2):126–130
10. HAPO Study Cooperative Research
Group. The Hyperglycemia and Adverse
Pregnancy Outcome (HAPO) study. Int J
Gynecol Obstet 2002;78:69–77
11. HAPO Study Cooperative Research
Group. Hyperglycemia and adverse preg-
nancyoutcomes.NEnglJMed2008;358:
1991–2002
12. Cole TJ, Freeman JV, Preece MA. British
1990 growth reference centiles for
weight,height,bodymassindexandhead
circumference ﬁtted by maximum penal-
ized likelihood. Stat Med 1998;17(4):
407–429
13. Kim S, Min W-K, Chun S, Lee W, Chung
H-J, Lee PR, Kim A. Quantitative risk es-
timationforlargeforgestationalageusing
the area under the 100-g oral glucose tol-
erance test curve. J Clin Lab Anal 2009;
23:213–236
14. Silverman BL, Rizzo T, Green OC, Cho
NH, Winter RJ, Ogata ES, Richards GE,
Metzger BE. Long-term prospective eval-
uation of offspring of diabetic mothers.
Diabetes 1991;40:(Suppl. 2):121–125
15. Pettitt DJ. Summary and comment of: Sil-
verman BL, Rizzo T, Green OC, Cho NH,
Winter RJ, Ogata ES, Richards GE,
Metzger BE. Long-term prospective eval-
uation of offspring of diabetic mothers
(Diabetes 1991;40:(Suppl. 2):121–25).
Diabetes Spectrum 1992;5:39–40
Pettitt and Associates
care.diabetesjournals.org DIABETES CARE, VOLUME 33, NUMBER 6, JUNE 2010 1223